Zacks Investment Research on MSNOpinion

New Strong Buy Stocks for November 4th

List today: CorMedix Inc. CRMD: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year ...
Wegovy-maker Novo Nordisk presented new data on Wednesday showing its experimental weight-loss pill improved blood sugar ...
Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera ...
The lowest doses of Eli Lilly’s Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.
The battle for control of a promising obesity drug maker has intensified, with one pharmaceutical giant upping its bid to $10 ...
The Trump administration is nearing deals with drugmakers Eli Lilly and Novo Nordisk to offer some of their obesity drugs to consumers for as low as $149 per month, according to two people familiar ...
Eli Lilly and Novo Nordisk are expected to announce deals with the Trump administration to cut prices of their weight-loss drugs in exchange for Medicare coverage, a White House source told Reuters on ...
The company is preparing to launch a more convenient form of its weight loss treatment that has investors excited.
Novo Nordisk made a much higher offer to acquire a biotech Pfizer was already set to buy out. Losing this battle would be more damaging to Pfizer than to Novo Nordisk. Even so, both companies look ...
If you act quickly, you can use these SHiFT promo codes to snag epic loot and tons of Vault Hunter cosmetics in Borderlands 4. Tyler is a writer under CNET's home energy and utilities category. He ...
Novo Nordisk cut its 2025 profit and sales forecasts as slower GLP-1 growth and pricing pressure hit margins. ・Q3 sales rose ...